Targeting Tumor Vasculature using αVEGFR2 Chemically Self-Assembled Nanorings (CSANs)
2022-04
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Targeting Tumor Vasculature using αVEGFR2 Chemically Self-Assembled Nanorings (CSANs)
Authors
Published Date
2022-04
Publisher
Type
Presentation
Abstract
Vascular normalization involves the use of anti-angiogenic therapeutics to restore proper tumor oxygenation and perfusion to improve the effectiveness of anti-cancer therapeutics. The VEGFR played a vital role in cancer by promoting neovascularization for continuing tumor growth. The VEGFR2 protein is expressed and purified with IMAC and SEC and evaluated with flow cytometry. The Ability of VEGFR2 CSANs to Inhibit VEGF Induced Signaling and Proliferation is determined with enzyme-linked immunosorbent assay (ELISA) and IncuCyte. Consistent with the hypothesis, the VEGFR2-16 affibody was expressed and oligomerized successfully into CSANs, and the ability of targeting was determined.
Keywords
Description
Faculty Mentor: Carston R. Wagner
Related to
Replaces
License
Series/Report Number
Funding information
This project was sponsored by the University of Minnesota’s Undergraduate Research Opportunities Program (UROP).
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Wang, Wanrui. (2022). Targeting Tumor Vasculature using αVEGFR2 Chemically Self-Assembled Nanorings (CSANs). Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/261416.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.